London-based Huma Therapeutics, which uses AI to help developers make health apps, raised an $80M Series D at a near-$1B valuation, for $300M in total funding (Saritha Rai/Bloomberg)

Saritha Rai / Bloomberg:
London-based Huma Therapeutics, which uses AI to help developers make health apps, raised an $80M Series D at a near-$1B valuation, for $300M in total funding  —  The Series D financing for the London-headquartered firm includes investments by drug makers AstraZeneca Plc and Bayer AG …